Thus, to examine how TLR activation affected pro-survival genes in freshly obtained CD138+ cells from MM patients, we treated the cells with a cocktail of TLR agonists covering TLR1–TLR9 for 6 hours. This evidence concerns the gene TLR1 and Miyoshi myopathy.